|
Spearheading
the Global Expansion of China's Top
Pharma & TCM Firms
|
|
Watch TV Ads
|
Launch of LIVOTIDE - China’s
leading Liver Protection Product
China’s leading herb-based liver-protection product, Livotide (古蔺肝苏) will be launched in the Singapore market on 8 October 2006 at the Alumni Medical Center of the Singapore General Hospital. More than 100 Chinese medical practitioners and other professionals have registered to attend the product launch. There is substantial interest in Livotide amongst the medical profession, as indicated in pre-launch surveys. Livotide has been approved for the protection and strengthening of the liver, liver detoxification (e.g. from alcohol) and the alleviation of jaundice. Clinical trials in China have confirmed its effectiveness in treating a range of liver conditions including acute and chronic hepatitis B, liver fibrosis and even liver cancer. Livotide is derived from the herb Herba Penthori Chinensis and is used by over 2,000 hospitals. Distributors from various countries have started to approach Xing Ling to initiate co-operation. |
|
© Copyright
2005-2006 Xing Ling International Pte Ltd. All Rights Reserved.
|